Mosaic ImmunoEngineering Inc (CPMV)

[Poker MVP]

PTSC Investment Profile updated as of 9/22/05 which includes the following known information;

Recent Key Developments: 9/14/05 - “PTSC FY ‘05 rev. $2.98 million v. $76,417 a year ago. Net Loss ($2,693,550) or ($0.01) per diluted share v. net loss ($4,149,978) or ($0.03) per diluted share a year go.”

“During the 3rd quarter of FY ‘05 and the 1st quarter of FY ‘06, PTSC entered into licensing agreements w/AMD & Intel. The agreement w/AMD was worth $3,050,000. The $20 million agreement w/Intel produced net proceeds of approximately $6,700,000 for PTSC after revenue sharing w/TPL and the establishment of a working capital fund established by the two companies to pursue future settlements.”

Very encouraging and optimistic way to say “pursue future settlements” rather than “prosecute patent infringers.”